ENDRA LIFE SCIENCES INC. Proceeds from Collection of Notes Receivable
ENDRA LIFE SCIENCES INC. (NDRA) reported Proceeds from Collection of Notes Receivable of $308.60 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-16.
Discontinued › Cash Flow
us-gaap:ProceedsFromCollectionOfNotesReceivable · last filed 2023-03-16
- ENDRA LIFE SCIENCES INC. proceeds from collection of notes receivable for fiscal 2022 was $308.60K.
| Period end | Proceeds from Collection of Notes Receivable 1 month | Proceeds from Collection of Notes Receivable 12 month |
|---|---|---|
| 2022-12-31 | $308.60K 10-K · filed 2023-03-16 | |
| 2020-04-27 | $308.60K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |